Doç. Dr. TOLGA KÖŞECİ

Yayın Ağı

Makaleler 17

1. Prognostic Significance of C-PLAN Index in Patients Treated with Immunotherapy for Non-Small-Cell Lung Cancer

NURANSOY CENGİZ A., BOZKURT O., Cengiz M., ÖZKAN M., İNANÇ M., KEFELİ U., et al.

Journal of Clinical Medicine , cilt.15, sa.2, 2026 (SCI-Expanded, Scopus)

2. Impact of renin–angiotensin system inhibitors on the clinical outcomes of nivolumab therapy in metastatic non–small cell lung cancer

Mutlu Ozkan E., Karadağ I., Sahın E., NURANSOY CENGİZ A., Cengız M., Can Guven D., et al.

Expert Review of Anticancer Therapy , 2026 (SCI-Expanded, Scopus)

3. HALP-H Index as a Prognostic Biomarker for Predicting Pathological Complete Response in Early-Stage HER2-Positive Breast Cancer—A Multicenter Retrospective Cohort Study

Seyyar M., Şancı P. C., KÖŞECİ T., Karakayalı A., Akdağ M. Ö., Temi Y. B., et al.

Journal of Clinical Medicine , cilt.14, sa.13, 2025 (SCI-Expanded, Scopus)

4. Evaluation of the efficacy of regorafenib treatment by location and RAS mutation in metastatic colon cancer

Ata S., Gülmez A., KÖŞECİ T., Özalp Ö., Çil T., Duman B. B.

Medicine (United States) , cilt.104, sa.26, 2025 (SCI-Expanded, Scopus)

5. The prognostic value of halp score in predicting the efficacy of nivolumab treatment in metastatic malignant melanoma patients: A real-life, retrospective, single center analysis

Ata S., KÖŞECİ T., Benli B. A., Bayhan A. Z., Kesen O., Solmaz A. A., et al.

Medicine (United States) , cilt.104, sa.18, 2025 (SCI-Expanded, Scopus)

6. Nonsteroidal Antiinflamatuvar İlaçların Kemopreventif Etkileri

Ölmez S., Köşeci T., Kozanoğlu M. E.

Sağlık bilimlerinde değer (Online) , cilt.15, sa.2, ss.315-320, 2025 (TRDizin)

7. Prognostic Significance of the Combined Albumin-To-Alkaline Phosphatase Ratio (AAPR) and Haemoglobin–Albumin–Lymphocyte–Platelet (HALP) Score in Patients with Metastatic Renal Cell Carcinoma Treated by Targeted Therapy: A New Prognostic Combined Risk Scoring

KÖŞECİ T., Seyyar M., Kıdı M. M., Biter S., Eser K., KEFELİ U., et al.

Journal of Clinical Medicine , cilt.14, sa.5, 2025 (SCI-Expanded, Scopus)

8. Regorafenib Treatment for Recurrent Glioblastoma Beyond Bevacizumab-Based Therapy: A Large, Multicenter, Real-Life Study

Tünbekici S., Yuksel H. c., Acar C., Sahin G., Orman S., Majidova N., et al.

Cancers , cilt.17, sa.1, 2025 (SCI-Expanded, Scopus)

9. Exploring the Impact of Cytogenetic Abnormalities on Treatment Responses and Survival Outcomes in Multiple Myeloma: A Single-Centre Experience of 13 Years of Follow-Up

Bayram E., Köşeci T., Mete B., Toyran T., Kara İ. O.

BIOMEDICINES , cilt.12, sa.5, ss.1-13, 2024 (SCI-Expanded, Scopus)

10. Efficacy of everolimus plus hormonal treatment after cyclin-dependent kinase inhibitor; real-life experience, A TOG study

Beypınar İ., Demir H., YASLIKAYA Ş., KÖŞECİ T., Demir B., Çolak G., et al.

Breast Cancer Research and Treatment , 2024 (SCI-Expanded, Scopus)

11. Diagnostic Significance of Pre-Treatment Prognostic Nutritional Index, Platelet/Albumin Ratio and Red Cell Distribution Width in Patients with Differentiated Glioblastoma from Brain Metastasis

OLGUN P., KÖŞECİ T., BAYRAM E., HAKSÖYLER V., BOZKURT DUMAN B., ÇİL T.

Eurasian Journal of Medical Investigation , cilt.7, sa.4, ss.426-432, 2023 (TRDizin)

12. Importance of Prognostic Nutritional Index in Patients with Metastatic Breast Cancer Treated with Trastuzumab Emtansine

KÖŞECİ T., BULUT G., ATA S., BAYRAM E., ÇİL T., ESER K.

Eurasian Journal of Medical Investigation , cilt.6, sa.4, ss.484-490, 2022 (TRDizin)

13. Erişkin Dönemin Nadir Görülen Beyin Tümörü: Medulloblastom Tanılı 28 Hastanın Demografik Özellikleri

KÖŞECİ T., ATA S., SEYYAR M., OLGUN P., BAYRAM E., ESER K., et al.

Çukurova Anestezi ve Cerrahi Bilimler Dergisi , cilt.5, sa.2, ss.235-240, 2022 (TRDizin)

14. Clinicopathological Features of Gastroenteropancreatic Neuroendocrine Tumors: A Retrospective Evaluation of 149 Cases

KÖŞECİ T., OLGUN P., ATA S., SEYYAR M., TAŞ Z. A., BAYRAM E., et al.

Eurasian Journal of Medical Investigation , cilt.6, sa.2, ss.222-226, 2022 (TRDizin)

15. Prognostic importance of peripheral blood parameters in HER-2 positive metastatic breast cancer treated by pertuzumab, trastuzumab and docetaxel

KÖŞECİ T., OLGUN P., ATA S., BAYRAM E., SUNGUR M. A., ESER K., et al.

Medical Science and Discovery , cilt.8, sa.12, ss.730-734, 2021 (Hakemli Dergi) Sürdürülebilir Kalkınma

16. Effectiveness and Reliability of Scalp Cooling in Preventing Hair Loss Caused by Chemotherapy

HAKSÖYLER V., KÖŞECİ T., OLGUN P., BAYRAM E., ÇAPARLAR M. A.

Kocaeli Tıp Dergisi , cilt.10, sa.2, ss.133-140, 2021 (TRDizin)

17. Investigation of the change in the biological structure of the tumor in metastatic breast cancer

HAKSÖYLER V., KÖŞECİ T., ÇİL T., BOZKURT DUMAN B., OLGUN P., BAYRAM E., et al.

Medical Science and Discovery , cilt.8, sa.3, ss.171-174, 2021 (Hakemli Dergi)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 4

1. Management of Hepatocellular Carcinoma in a Patient with Glycogen Storage Disease Type 1a.

BULUT F. D., BALLI H. T., ŞAHİN B., KOR D., BURGAÇ E., KAPLAN İ., et al.

Society for the Study of Inborn Errors of Metabolism Annual Symposium, Sydney, Avustralya, 30 Ağustos - 02 Eylül 2022, (Özet Bildiri)

2. MANTLE HÜCRELİ LENFOMALI HASTADA SKUAMÖZ HÜCRELİ AKCİĞER KANSERİ BİRLİKTELİĞİ

BAYRAM E., KÖŞECİ T., ADAMHASAN F., GÜMÜRDÜLÜ D., BOZKURT DUMAN B., ÇİL T.

6. TÜRK TIBBI ONKOLOJİ KONGRESİ, Türkiye, 23 Mart 2016, (Özet Bildiri)

3. PROSTAT BEZİNİN PRİMER DİFFÜZ BÜYÜK B HÜCRELİ LENFOMASI:NADİR GÖRÜLEN BİR OLGU

KÖŞECİ T., HAKSÖYLER V., BAYRAM E., POLAT KELLE A., BOZKURT DUMAN B., ÇİL T.

6. TÜRK TIBBI ONKOLOJİ KONGRESİ, Türkiye, 23 Mart 2016, (Özet Bildiri)

4. MULTİPLE KARACİĞER METASTAZINA BAĞLI BİLİRUBİN YÜKSEKLİĞİ OLAN KOLOREKTAL KANSERLİ HASTADA 5 FLUOROURASİL DOZ REDUKSİYONU İLE ELDE EDİLEN TEDAVİ ETKİNLİĞİ.OLGU SUNUMU

HAKSÖYLER V., KÖŞECİ T., BAYRAM E., POLAT KELLE A., BOZKURT DUMAN B., ÇİL T.

6.TÜRK TIBBİ ONKOLOJİ KONGRESİ, Antalya, Türkiye, 23 Mart 2016, (Özet Bildiri)

Yayınlar & Eserler